Page last updated: 2024-08-24

lamivudine and Myalgia

lamivudine has been researched along with Myalgia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Chiang, BL; Lai, HS; Lee, CY; Tsai, MK; Yang, CY; Yang, YW1
Barchiesi, F; Cirioni, O; Fragola, V; Gabrielli, E; Giacometti, A; Marchionni, E; Massella, M; Weimer, LE1

Trials

1 trial(s) available for lamivudine and Myalgia

ArticleYear
Telbivudine for renal transplant recipients with chronic hepatitis B infection: a randomized controlled trial with early termination.
    Clinical and experimental nephrology, 2020, Volume: 24, Issue:5

    Topics: Adult; Aged; Antiviral Agents; Creatinine; Early Termination of Clinical Trials; Female; Glomerular Filtration Rate; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Kidney; Kidney Failure, Chronic; Kidney Transplantation; Lamivudine; Male; Middle Aged; Myalgia; Prospective Studies; Telbivudine; Time Factors

2020

Other Studies

1 other study(ies) available for lamivudine and Myalgia

ArticleYear
Sustained increase of serum creatine phosphokinase levels and progressive muscle abnormalities associated with raltegravir use during 32-week follow-up in an HIV-1 experienced patient on simplified HAART regimen, intolerant to protease inhibitors and abac
    The West Indian medical journal, 2013, Volume: 62, Issue:4

    Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Creatine Kinase; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Muscle Weakness; Myalgia; Pyrrolidinones; Raltegravir Potassium; Zidovudine

2013